Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Non-Hodgkin lymphoma risk in adults living with HIV across five continents

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIV

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Risk factors for antiretroviral therapy (ART) discontinuation in a large multinational trial of early ART initiators

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Algorithmic prediction of HIV status using nation-wide electronic registry data

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Primary health care: an opportunity for early identification of people living with undiagnosed HIV infection

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. A modeling study of the Danish HIV epidemic in men who have sex with men: travel, pre-exposure prophylaxis and elimination

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Niels Obel
  • AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord
View graph of relations

OBJECTIVE: To compare non-Hodgkin lymphoma (NHL) incidence rates in adults who started antiretroviral therapy (ART) across the Asia-Pacific, South Africa, Europe, Latin, and North America.

METHODS: We included cohort data of adults living with HIV who started ART after 1995 within the framework of the International epidemiology Databases to Evaluate AIDS (IeDEA) and the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE). We used flexible parametric survival models to compare regional NHL rates at 2 years after ART start and to identify risk factors for NHL.

RESULTS: We included 210 898 adults with 1.1 million person-years (pys) of follow-up and 1552 incident NHL cases (raw overall incidence rate 142/100 000 pys). After adjusting for age at ART start, first-line ART regimen, calendar period of ART start, and especially current CD4 cell count, NHL rates were similar across regions for most population groups. However, South African women remained at increased risk of developing NHL compared with their European counterparts [adjusted hazard ratio [aHR] 1.79, 95% CI 1.19-2.70]. In Europe, Latin, and North America, NHL risk was highest in MSM (aHR 1.30, 95% CI 1.14-1.48), followed by heterosexual men (referent), and women (aHR 0.66, 95% CI 0.57-0.78).

CONCLUSIONS: The risk of developing NHL is higher in women in South Africa than in Europe and higher in MSM compared with heterosexual men and women. Reasons for these differences remain unclear. Early ART access and regular patient monitoring to avert low CD4 cell counts remain key for NHL prevention.

Original languageEnglish
JournalAIDS (London, England)
Volume32
Issue number18
Pages (from-to)2777-2786
Number of pages10
ISSN0269-9370
DOIs
Publication statusPublished - 28 Nov 2018

ID: 56394974